Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL

Methods for ex vivo therapy using peptide-loaded antigen presenting cells for the activation of CTL

US Patent 5846827 · Granted Dec 8, 1998

Estimated economic value: $370,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human alpha fetoprotein-specific t cell receptors and uses thereof2024
Prostate-associated antigens and vaccine-based immunotherapy regimens2021
Human alpha fetoprotein-specific murine T cell receptors and uses thereof2021
Method of developing a vaccine using peptide-poly IC complexes2019
Method of developing a vaccine using peptide-poly IC complexes2017
Prostate-associated antigens and vaccine-based immunotherapy regimens2016
HLA binding motifs and peptides and their uses2016
HLA binding motifs and peptides and their uses2016
Inducing cellular immune responses to Plasmodium falciparum using peptide and nu2016
Inducing cellular immune responses to Plasmodium falciparum using peptide and nu2016
Prostate-associated antigens and vaccine-based immunotherapy regimens2015
HER-2 peptides and vaccines2014